2-(1H-benzimidazol-2-yl)-3-hydroxy-4-[3-[(4-methylphenyl)methyl]-4-oxoquinazolin-2-yl]sulfanylbut-2-enenitrile

C27H21N5O2S — CID 4687187

IUPAC2-(1H-benzimidazol-2-yl)-3-hydroxy-4-[3-[(4-methylphenyl)methyl]-4-oxoquinazolin-2-yl]sulfanylbut-2-enenitrile
SMILESCc1ccc(Cn2c(SCC(O)=C(C#N)c3nc4ccccc4[nH]3)nc3ccccc3c2=O)cc1
InChIInChI=1S/C27H21N5O2S/c1-17-10-12-18(13-11-17)15-32-26(34)19-6-2-3-7-21(19)31-27(32)35-16-24(33)20(14-28)25-29-22-8-4-5-9-23(22)30-25/h2-13,33H,15-16H2,1H3,(H,29,30)
InChIKeyQOCDLBZHKZOOKS-UHFFFAOYSA-N
MW479.57 g/mol
LogP5.21
Rot. Bonds6

About 2-(1H-benzimidazol-2-yl)-3-hydroxy-4-[3-[(4-methylphenyl)methyl]-4-oxoquinazolin-2-yl]sulfanylbut-2-enenitrile

2-(1H-benzimidazol-2-yl)-3-hydroxy-4-[3-[(4-methylphenyl)methyl]-4-oxoquinazolin-2-yl]sulfanylbut-2-enenitrile (PubChem CID 4687187) has the molecular formula C27H21N5O2S and a molecular weight of 479.57 g/mol. Its IUPAC name is 2-(1H-benzimidazol-2-yl)-3-hydroxy-4-[3-[(4-methylphenyl)methyl]-4-oxoquinazolin-2-yl]sulfanylbut-2-enenitrile.

Molecular Properties

Compound Name2-(1H-benzimidazol-2-yl)-3-hydroxy-4-[3-[(4-methylphenyl)methyl]-4-oxoquinazolin-2-yl]sulfanylbut-2-enenitrile
PubChem CID4687187
Molecular FormulaC27H21N5O2S
Molecular Weight479.57 g/mol
Exact Mass479.14
IUPAC Name2-(1H-benzimidazol-2-yl)-3-hydroxy-4-[3-[(4-methylphenyl)methyl]-4-oxoquinazolin-2-yl]sulfanylbut-2-enenitrile
SMILESCc1ccc(Cn2c(SCC(O)=C(C#N)c3nc4ccccc4[nH]3)nc3ccccc3c2=O)cc1
InChIInChI=1S/C27H21N5O2S/c1-17-10-12-18(13-11-17)15-32-26(34)19-6-2-3-7-21(19)31-27(32)35-16-24(33)20(14-28)25-29-22-8-4-5-9-23(22)30-25/h2-13,33H,15-16H2,1H3,(H,29,30)
InChIKeyQOCDLBZHKZOOKS-UHFFFAOYSA-N
XLogP5.21
TPSA107.59 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds6
Heavy Atoms35
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500479.57
LogP ≤ 55.21
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'acyclic_C=C-O', 'substructure': 'N/A'}, {'alert_name': 'conjugated_nitrile_group', 'substructure': 'N/A'}

Analyze 2-(1H-benzimidazol-2-yl)-3-hydroxy-4-[3-[(4-methylphenyl)methyl]-4-oxoquinazolin-2-yl]sulfanylbut-2-enenitrile with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-(1H-benzimidazol-2-yl)-3-hydroxy-4-[3-[(4-methylphenyl)methyl]-4-oxoquinazolin-2-yl]sulfanylbut-2-enenitrile?
The IUPAC name of 2-(1H-benzimidazol-2-yl)-3-hydroxy-4-[3-[(4-methylphenyl)methyl]-4-oxoquinazolin-2-yl]sulfanylbut-2-enenitrile (CID 4687187) is 2-(1H-benzimidazol-2-yl)-3-hydroxy-4-[3-[(4-methylphenyl)methyl]-4-oxoquinazolin-2-yl]sulfanylbut-2-enenitrile.
What is the SMILES notation for 2-(1H-benzimidazol-2-yl)-3-hydroxy-4-[3-[(4-methylphenyl)methyl]-4-oxoquinazolin-2-yl]sulfanylbut-2-enenitrile?
The canonical SMILES for 2-(1H-benzimidazol-2-yl)-3-hydroxy-4-[3-[(4-methylphenyl)methyl]-4-oxoquinazolin-2-yl]sulfanylbut-2-enenitrile is Cc1ccc(Cn2c(SCC(O)=C(C#N)c3nc4ccccc4[nH]3)nc3ccccc3c2=O)cc1.
What is the InChIKey of 2-(1H-benzimidazol-2-yl)-3-hydroxy-4-[3-[(4-methylphenyl)methyl]-4-oxoquinazolin-2-yl]sulfanylbut-2-enenitrile?
The InChIKey is QOCDLBZHKZOOKS-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H21N5O2S/c1-17-10-12-18(13-11-17)15-32-26(34)19-6-2-3-7-21(19)31-27(32)35-16-24(33)20(14-28)25-29-22-8-4-5-9-23(22)30-25/h2-13,33H,15-16H2,1H3,(H,29,30).
What are the key properties of 2-(1H-benzimidazol-2-yl)-3-hydroxy-4-[3-[(4-methylphenyl)methyl]-4-oxoquinazolin-2-yl]sulfanylbut-2-enenitrile?
2-(1H-benzimidazol-2-yl)-3-hydroxy-4-[3-[(4-methylphenyl)methyl]-4-oxoquinazolin-2-yl]sulfanylbut-2-enenitrile has a molecular weight of 479.57 g/mol, XLogP of 5.21, 6 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(1H-benzimidazol-2-yl)-3-hydroxy-4-[3-[(4-methylphenyl)methyl]-4-oxoquinazolin-2-yl]sulfanylbut-2-enenitrile is sourced from PubChem (CID 4687187), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).